Effects of obstructive sleep apnea on endothelin-1 and blood pressure

Journal of Hypertension

Volumn 17, Issue 1, 1999, Pages 61-66

  Phillips, Bradley G ^a   Narkiewicz, Krzysztof ^a   Pesek, Catherine A ^a   Haynes, William G ^a   Dyken, Mark E ^a   Somers, Virend K ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Blood pressure; Endothelin; Hypoxia; Norepinephrine; Obstructive sleep apnea; Plasma renin activity

Indexed keywords

ENDOTHELIN 1; NORADRENALIN; RENIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD OXYGEN TENSION; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMODYNAMICS; HUMAN; MALE; MEAN ARTERIAL PRESSURE; PLASMA RENIN ACTIVITY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RECURRENT DISEASE; SLEEP APNEA SYNDROME; VASOCONSTRICTION;

EID: 0032976443     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917010-00010     Document Type: Article

References (46)

1. Lavie P, Ben-Yosef R, Rubin AE. Prevalence of sleep apnea syndrome among patients with essential hypertension. Am Heart J 1984; 108:373-376.
2. He J, Kryger MH, Zorick FJ, Conway W, Roth T. Mortality and apnea index in obstructive sleep apnea: experience in 385 male patients. Chest 1988; 94:9-14.
3. Koskenvuo M, Kaprio J, Partinen M, Langinvanio H, Sama S, Heikkila K. Snoring as a risk factor for hypertension and angina pectoris. Lancet 1985; i:89-95.
4. Wieczorek I, Haynes WG, Webb DJ, Ludlam CA, Fox KAA. Raised plasma endothelin in unstable angina and non-Q wave myocardial infarction: relation to cardiovascular outcome. Br Heart J 1994; 72:436-441.
5. Dyken ME, Somers VK, Yamada T, Adams HP Jr, Zong-Ying R, Zimmerman MB. Investigating the relationship between stroke and obstructive sleep apnea. Stroke 1996; 27:401-407.
6. Kales A, Cadieux RJ, Shaw III LC, Vela-Bueno A, Bixler EO, Schneck DW, et al. Sleep apnoea in a hypertensive population. Lancet 1984; ii:1005-1008.
7. Isaksson H, Svanborg E. Obstructive sleep apnea syndrome in male hypertensives, refractory to drug therapy, nocturnal automatic blood pressure measurements: an aid to diagnosis? Clin Exp Hypertens 1991; A13:1195-1212.
8. McAlister FA, Lewanczuk RZ, Teo KK. Resistant hypertension: an overview. Can J Cardiol 1996; 12:822-828.
9. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96:1897-1904.
10. Somers VK, Zavala DC, Mark AL, Abboud FM. Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans. J Appl Physiol 1989; 67:2095-2100.
11. Somers VK, Zavala DC, Mark AL, Abboud FM. Contrasting effects of hypoxia and hypocapnia on ventilation and sympathetic activity in humans. J Appl Physiol 1989; 67:2101-2106.
12. Cortelli P, Parchi P, Sforza E, Contin M, Pierangeli G, Barletta G, et al. Cardiovascular autonomic dysfunction in normotensive awake subjects with obstructive sleep apnoea syndrome. Clin Auton Res 1994; 4:57-62.
13. Ritthaler T, Schrickor K, Kees F, Kramer B, Kurtz A. Acute hypoxia stimulates renin secretion and renin gene expression in vivo but not in vitro. Am J Physiol 1997; 272:R1105-R1111.
14. Ehlenz K, Peter JH, Schneider H, Elle T, Scheere B, von Wichert P, et al. Renin secretion is substantially influenced by obstructive sleep apnea syndrome. In: Horne JA (editor): Sleep '90. Bochum: Pontenagel Press; 1990. pp. 193-195.
15. Baruzzi A, Riva R, Cirignotta F, Zucconi M, Cappelli M, Lugaresi E. Atrial natriuretic peptide and catecholamines in obstructive sleep apnea syndrome. Sleep 1991; 14:83-86.
16. Marrone O, Riccobono L, Salvaggio A, Mirabella A, Bonanno A, Bonsignore MR. Catecholamines and blood pressure in obstructive sleep apnea syndrome. Chest 1993; 103:722-727.
17. Dimsdale JE, Coy T, Ziegler MG, Ancoli-Israel S, Clausen J. The effect of sleep apnea on plasma and urinary catecholamines. Sleep 1995; 18:377-381.
18. Krieger J, Schmidt M, Sforza E, Lehr L, Imbs JL, Coumaros G, et al. Urinary excretion of guanosine 3×:5×-cyclic monophosphate during sleep in obstructive sleep apnoea patients with and without nasal continuous positive airway pressure treatment. Clin Sci 1989; 76:31-37.
19. Jennum P, Wildschiodtz G, Christensen NJ, Schwartz T. Blood pressure, catecholamines and pancreatic polypeptide in obstructive sleep apnea with and without nasal continuous positive airway pressure (nCPAP) treatment. Am J Hypertens 1989; 2:847-852.
20. Follenius M, Krieger J, Krauth MO, Sforza F, Brandenberger G. Obstructive sleep apnea treatment: peripheral and central effects on plasma renin activity and aldosterone. Sleep 1991; 14:211-217.
21. Fletcher EC, Miller J, Schaaf JW, Fletcher JG. Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep 1987; 10:35-44.
22. Hedner J, Darpö B, Ejnell H, Cartson J, Caidahl K. Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications. Eur Respir J 1995; 8:222-229.
23. Eisenberg E, Zimlichman R, Lavie P. Plasma norepinephrine levels in patients with sleep apnea syndrome. N Engl J Med 1990; 322:932-933.
24. Lapinski M, Przybylowski T, Lewandowski J, Januszewicz A, Wocial B, Kowalski J, et al. Diurnal blood pressure rhythm and urinary catecholamine excretion in obstructive sleep apnoea and essential hypertension. J Hypertens 1993; 11 (Suppl 5):S292-S293.
25. Kourembanas S, Marsden PA, McQuillan LP, Faller DV. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest 1991; 88:1054-1057.
26. Rakugi H, Tabuchi Y, Nakamaru M, Nagano M, Higashimori K, Mikami H, et al. Evidence for endothelin-1 release from resistance vessels of rats in response to hypoxia. Biochem Biophys Res Commun 1990; 169:973-977.
27. Perrella MA, Edell ES, Krowka MJ, Cortese DA, Burnett JC Jr. Endothelium-derived relaxing factor in pulmonary and renal circulations during hypoxia. Am J Physiol 1992; 263:R45-R50.
28. Nir A, Clavell AL, Heublein D, Aarhus LL, Burnett JC Jr. Acute hypoxia and endogenous renal endothelin. J Am Soc Nephrol 1994; 4:1920-1924.
29. Miller WL, Redfield MM, Burnett JC Jr. Integrated cardiac, renal, and endocrine actions of endothelin. J Clin Invest 1989' 83:317-320.
30. Lerman A, Hildebrand FL Jr, Aarhus LL, Burnett JC Jr. Endothelin has biological actions at pathophysiological concentration. Circulation 1991; 83:1808-1814.
31. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332:411-415.
32. Khraibi AA, Heublein DM, Knox FG, Burnett JC Jr. Increased plasma level of endothelin-1 in the Okamoto spontaneously hypertensive rat. Mayo Clin Proc 1993; 68:42-46.
33. Warner TD, Battistini B, Doherty AM, Corder R. Endothelin receptor antagonists: actions and rationale for their development. Biochem Pharmacol 1994; 48:625-635.
34. Masaki T, Kimura S, Yanagisawa M, Goto K. Molecular and cellular mechanism of endothelin regulation: implications for vascular function. Circulation 1991; 84:1457-1468.
35. Komuro I, Kurihara H, Sugiyama T, Yoshizumi M, Takaku F, Yazaki Y. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle. FEBS Lett 1988; 238:249-252.
36. Dubin D, Pratt RE, Cooke JP, Dzau VJ. Endothelin, a potent vasconstrictor, is a vascular smooth muscle mitogen. J Vasc Med Biol 1989; 1:150-154.
37. Ito H, Hirata V, Hiroe M, Tsujino M, Adachi S, Takamoto T, et al. Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiocytes. Circ Res 1991; 69:209-215.
38. Badr KF, Murray JJ, Breyer MD, Takahashi K, Inagami T, Harris RC. Mesangial cell, glomerular and renal vascular response to endothelin in the rat kidney: elucidation of signal transduction pathways. J Clin Invest 1989; 83:336-342.
39. + exchange, c-fos expression, mitogenesis in rat mesangial cells. J Clin Invest 1989; 83:708-712.
40. Saarelainen S, Seppala E, Laasonen K, Hasan J. Circulating endothelin-1 in obstructive sleep apnea. Endothelium 1997; 5:115-118.
41. Haynes WG, Hamer DW, Robertson CE, Webb DJ. Plasma endothelin following cardiac arrest: differences between survivors and non-survivors. Resuscitation 1994; 27:117-122.
42. Haynes WG, Webb DJ. The endothelin family of peptides: local hormones with diverse roles in health and disease? Clin Sci 1993; 84:485-500.
43. Yoshimoto S, Ishizaki Y, Sasaki T, Murota SI. Effects of carbon dioxide and oxygen on endothelin production by cultured porcine cerebral endothelial cells. Stroke 1991; 22:378-383.
44. Yoshizumi M, Kurihara H, Sugiyama T, Takaku F, Yanagisawa M, Masaki T, et al. Hemodynamic shear stress stimulates endothelin production by cultured endothelial cells. Biochem Biophys Res Commun 1989; 161:859-864.
45. Prasad MR, Jones RM, Kreutzer DL. Release of endothelin from cultured bovine endothelial cells. J Mol Cell Cardiol 1991; 23:655-658.
46. Mulder P, Richard V, Derumeaux G, Hogie M, Henry JP, Lallemand F, et al. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling. Circulation 1997; 96:1976-1982.